Health Condition 1: J17- Pneumonia in diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
Jehangir Clinical Development Centre
Eligibility
Inclusion criteria
Inclusion criteria: This study will include records of patients =18 years and who: ? have been hospitalized (transferred) from emergency or outpatient departments to an inpatient ward (inclusive of the intensive care unit [ICU]) during the selected periods of enrollment (01 January 2019 – 31 December 2019, and 01 January 2022 – 30 June 2022). ? have received a diagnosis of lower tract respiratory infection (LTRI) (clinical diagnosis confirmed by radiology X-ray or computed tomography [CT] scan), inclusive of influenza and COVID-19 pneumonia (the latter, relevant for the first half of the year 2022). ? have an LTRI diagnosis that is compatible with a community source of infection before hospitalization as determined by the participating investigator Patients with a diagnosis of LTRI could include the following 3 categories: a) have newly diagnosed CAP during the study period of enrollment with no history of CAP before the start of the study period of enrollment b) have a recurrence during the study period of enrollment, of a CAP that occurred before the start of the study period of enrollment The date of first admission to the hospital for the above two patient categories (a and b) during the study period of enrollment is the index date. c) have a recurrence of a CAP (defined by a time interval of at least one month from the previous CAP admission) during the study period of enrollment. For this category of patients, the date of second admission would be considered as the index date.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this study is to estimate the burden of severe CAP (severe enough to cause hospitalization) in adults in India according to initial state of severity,microbiology, and a comprehensive list of risk factors. The study will cover two periods, before (year 2019) and during (first half of 2022) the COVID-19 pandemic.Timepoint: The timepoint for the outcome is after data collection. outcomes will be based on data extracted from two observation periods i.e. 2019 and first half of 2022. The timepoint for the outcome is after data collection. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Aquil Faruqui
JCDC-CRO (Jehangir Clinical Development Centre) www.jcdc.co.in
Outcome results
None listed